Clinical Trial Update: Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating fecal microbiota transplant as a treatment for hepatic encephalopathy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatic Encephalopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING